Vivo Bio Tech Limited (BOM:511509)
28.57
-0.33 (-1.14%)
At close: Feb 12, 2026
Vivo Bio Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 12.81 | 13.9 | 13.75 | 17.14 | 11.65 |
Cash & Short-Term Investments | 13.32 | 12.81 | 13.9 | 13.75 | 17.14 | 11.65 |
Cash Growth | -2.76% | -7.84% | 1.08% | -19.77% | 47.03% | 13.30% |
Accounts Receivable | - | 112.51 | 117.95 | 123.8 | 120.24 | 72.93 |
Other Receivables | - | 7.57 | 10.58 | 32.28 | 8.89 | - |
Receivables | - | 321.16 | 363.21 | 216.5 | 136.25 | 101.78 |
Inventory | - | 77.91 | 87.74 | 79.73 | 98.12 | 132.77 |
Other Current Assets | - | 7.5 | 7.48 | 7.94 | 8.81 | 24.66 |
Total Current Assets | - | 419.37 | 472.32 | 317.91 | 260.32 | 270.87 |
Property, Plant & Equipment | - | 772.24 | 814.65 | 799.62 | 824.13 | 410.35 |
Other Intangible Assets | - | 238.57 | 81.21 | 108.06 | 136.24 | 113.36 |
Long-Term Deferred Charges | - | 2.14 | 3.16 | 4.73 | 4.17 | 0.65 |
Other Long-Term Assets | - | - | 0 | 0 | - | - |
Total Assets | - | 1,432 | 1,371 | 1,230 | 1,225 | 795.23 |
Accounts Payable | - | 9.81 | 10.6 | 9.42 | 23.16 | 13.88 |
Accrued Expenses | - | 49.69 | 37.89 | 36.92 | 27.46 | 27.84 |
Short-Term Debt | - | 113.56 | 226.79 | 115.87 | 109.19 | 163.07 |
Current Portion of Long-Term Debt | - | 77.32 | 85.98 | 77.17 | 64.41 | - |
Current Income Taxes Payable | - | 28.03 | 17.89 | 10.31 | 7.59 | 13.58 |
Other Current Liabilities | - | -0 | -0 | 0 | - | - |
Total Current Liabilities | - | 278.4 | 379.15 | 249.69 | 231.81 | 218.37 |
Long-Term Debt | - | 349.37 | 417.87 | 430.92 | 500.78 | 146.5 |
Pension & Post-Retirement Benefits | - | 7.8 | 6.9 | 6.15 | 5.54 | 4.78 |
Long-Term Deferred Tax Liabilities | - | 17.7 | 23.42 | 24.85 | 15.44 | 0.31 |
Other Long-Term Liabilities | - | 0 | 0 | -0 | 0 | - |
Total Liabilities | - | 653.26 | 827.34 | 711.6 | 753.57 | 369.96 |
Common Stock | - | 171.65 | 149.04 | 149.04 | 142.64 | 134.2 |
Additional Paid-In Capital | - | 216.48 | 149.58 | 149.58 | 128.13 | 105.2 |
Retained Earnings | - | 288.96 | 216.13 | 190.87 | 164.38 | 142.36 |
Comprehensive Income & Other | - | 101.97 | 29.25 | 29.25 | 36.15 | 43.51 |
Shareholders' Equity | 967.69 | 779.05 | 544 | 518.73 | 471.28 | 425.27 |
Total Liabilities & Equity | - | 1,432 | 1,371 | 1,230 | 1,225 | 795.23 |
Total Debt | 565.32 | 540.25 | 730.64 | 623.96 | 674.39 | 309.57 |
Net Cash (Debt) | -551.99 | -527.44 | -716.74 | -610.21 | -657.25 | -297.91 |
Net Cash Per Share | -28.58 | -34.49 | -42.97 | -41.16 | -46.40 | -21.97 |
Filing Date Shares Outstanding | 22.29 | 17.16 | 14.9 | 14.9 | 14.26 | 13.42 |
Total Common Shares Outstanding | 22.29 | 17.16 | 14.9 | 14.9 | 14.26 | 13.42 |
Working Capital | - | 140.97 | 93.17 | 68.22 | 28.51 | 52.5 |
Book Value Per Share | 50.13 | 45.39 | 36.50 | 34.81 | 33.04 | 31.69 |
Tangible Book Value | 750.61 | 540.48 | 462.79 | 410.67 | 335.05 | 311.91 |
Tangible Book Value Per Share | 38.89 | 31.49 | 31.05 | 27.56 | 23.49 | 23.24 |
Land | - | 210.67 | 228.8 | 228.8 | 228.8 | 26.99 |
Buildings | - | 174.89 | 174.89 | 174.89 | 174.89 | 31.66 |
Machinery | - | 753.76 | 751.87 | 747.18 | 717.51 | 604.69 |
Construction In Progress | - | 128.45 | 92.12 | 18.97 | 8.66 | 3.25 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.